Drug:
Reaction: DRUG HYPERSENSITIVITY
20250101 - 20251231
No. 401 - 500
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
401 | 25066898 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, CLONAZEPAM, OMALIZUMAB, OMALIZUMAB, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
402 | 25067182 |
CA |
58 | 2 |
Cushingoid, Thyroglossal cyst, Thyroid disorder, Oropharyngeal oedema, Drug hypersensitivity, Swelling, Swelling face, Dyspnoea, Angioedema, |
||||
IRBESARTAN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, |
||||
403 | 25067359 |
US |
1 | |
Injection site rash, Drug hypersensitivity, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
404 | 25067863 |
CA |
58 | 2 |
Abdominal pain, Abdominal pain lower, Blood pressure abnormal, Body temperature decreased, Bone pain, Breast cancer, Drug hypersensitivity, Ear swelling, Erythema, Headache, Illness, Joint stiffness, Oropharyngeal pain, Papule, Paraesthesia, Pruritus, Quality of life decreased, Rubber sensitivity, Sensitive skin, Skin exfoliation, Skin lesion, Skin plaque, Stress, Urticaria, Wound, Inappropriate schedule of product administration, Incorrect dose administered, Product availability issue, Product container issue, Product dose omission issue, Therapeutic response decreased, Therapy partial responder, |
||||
NAPROXEN, NAPROXEN SODIUM, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROXYZINE, |
||||
405 | 25067893 |
CA |
2 | |
Helicobacter infection, Lower limb fracture, Lupus vulgaris, Sleep disorder, Eye injury, Headache, Blood cholesterol increased, Confusional state, Abdominal pain upper, Infusion related reaction, Therapeutic response decreased, Pain, Drug ineffective, Vomiting, Psoriatic arthropathy, Anxiety, Glossodynia, Lower respiratory tract infection, Irritable bowel syndrome, Condition aggravated, Product use issue, Rheumatoid arthritis, Leukopenia, Contraindicated product administered, Sleep disorder due to general medical condition, insomnia type, Pericarditis, Fatigue, General physical health deterioration, Dizziness, Folliculitis, Anti-cyclic citrullinated peptide antibody positive, Type 2 diabetes mellitus, Road traffic accident, Deep vein thrombosis postoperative, Stomatitis, Urticaria, Hand deformity, Injury, Discomfort, Alopecia, Ulcer haemorrhage, Drug hypersensitivity, Maternal exposure during pregnancy, Synovitis, Impaired healing, Hypertension, Prescribed overdose, Gastrointestinal disorder, Product use in unapproved indication, Diarrhoea, Rash pruritic, Pemphigus, Peripheral swelling, Nasopharyngitis, Muscle injury, Intentional product use issue, Pyrexia, Systemic lupus erythematosus, Weight increased, Sinusitis, Gait inability, Duodenal ulcer perforation, Asthma, Chest pain, Off label use, Swelling, Autoimmune disorder, Fibromyalgia, Drug intolerance, Liver disorder, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROXYCHLOROQUINE, TOFACITINIB, TOFACITINIB, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB, ABATACEPT, ABATACEPT, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CALCIUM GLUCONATE, INFLIXIMAB, INFLIXIMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CALCIUM CARBONATE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, VITAMIN C, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, MAGNESIUM, CAFFEINE, LORAZEPAM, ERGOCALCIFEROL, LORAZEPAM, LANSOPRAZOLE, LISINOPRIL, |
||||
406 | 25068134 |
US |
77 | 2 |
Drug hypersensitivity, Swelling, Dyspepsia, |
||||
RIMEGEPANT SULFATE, |
||||
407 | 25068416 |
US |
2 | |
Drug hypersensitivity, |
||||
DUPILUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
408 | 25068418 |
US |
67 | 2 |
Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
409 | 25068834 |
CA |
58 | 2 |
Angioedema, Cushingoid, Drug hypersensitivity, Dyspnoea, Oropharyngeal oedema, Swelling, Swelling face, Thyroglossal cyst, Thyroid disorder, |
||||
IRBESARTAN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, |
||||
410 | 25069219 |
US |
51 | 2 |
Drug hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
411 | 25069417 |
CA |
53 | 1 |
Drug hypersensitivity, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CELECOXIB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, PREGABALIN, |
||||
412 | 25069678 |
CA |
64 | 2 |
Allergy to animal, Asthenia, Blood pressure diastolic abnormal, Blood pressure diastolic decreased, Blood pressure systolic abnormal, Blood pressure systolic increased, Conjunctivitis, Cyst, Deafness unilateral, Dental caries, Disability assessment scale score increased, Eye pruritus, Frustration tolerance decreased, Fungal infection, Heart rate decreased, Hernia pain, Herpes zoster, Infusion related reaction, Injection site bruising, Injection site extravasation, Joint instability, Lacrimation increased, Limb injury, Middle ear effusion, Pain, Plantar fasciitis, Poor venous access, Rheumatoid arthritis, Rhinorrhoea, Cough, Throat irritation, Toothache, Urinary tract infection, Drug hypersensitivity, Pruritus, Dizziness, Urticaria, Pyrexia, Arthralgia, Weight increased, Nasopharyngitis, Nausea, Joint swelling, Peripheral swelling, Pain in extremity, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, BISOPROLOL FUMARATE, LANSOPRAZOLE, LISINOPRIL, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, BISOPROLOL FUMARATE, FOLIC ACID, GABAPENTIN, HYDROMORPHONE HYDROCHLORIDE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE, METHOTREXATE SODIUM, PIOGLITAZONE HYDROCHLORIDE, PREDNISONE, SPIRONOLACTONE, |
||||
413 | 25069861 |
CA |
55 | 2 |
Aphonia, Bronchitis, Bronchospasm, COVID-19, Drug hypersensitivity, Illness, Occupational exposure to dust, Perfume sensitivity, Pneumonia, Sensitivity to weather change, Throat clearing, Upper respiratory tract infection, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
414 | 25070117 |
IL |
21 | 1 |
Drug hypersensitivity, |
||||
MIRIKIZUMAB-MRKZ, |
||||
415 | 25070234 |
US |
2 | |
Drug hypersensitivity, |
||||
ETANERCEPT, |
||||
416 | 25070316 |
39 | 1 | |
Stevens-Johnson syndrome, Miliaria, Drug hypersensitivity, |
||||
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, PREDNISONE, |
||||
417 | 25070330 |
US |
||
Drug hypersensitivity, |
||||
INCLISIRAN, |
||||
418 | 25070454 |
US |
15 | 2 |
Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
419 | 25070555 |
US |
2 | |
Drug hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
420 | 25071142 |
PT |
||
Type I hypersensitivity, Drug hypersensitivity, Mucocutaneous disorder, |
||||
IPRATROPIUM BROMIDE, |
||||
421 | 25071288 |
US |
66 | |
Pruritus, Chest pain, Chest discomfort, Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
422 | 25061406 |
US |
||
Drug hypersensitivity, |
||||
INFLIXIMAB, |
||||
423 | 25061542 |
CA |
61 | 2 |
Aphonia, Nasopharyngitis, Pneumonia, Productive cough, Road traffic accident, Sinusitis, Tendonitis, Tissue injury, Arthralgia, Weight decreased, Wheezing, Body temperature decreased, Drug hypersensitivity, Ear infection, Hypoventilation, Limb discomfort, Middle ear effusion, Cough, Rash, Product use issue, Off label use, |
||||
AMOXICILLIN, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, |
||||
424 | 25061584 |
CA |
25 | 1 |
Anaphylactic shock, Anxiety, Arthralgia, Arthritis, Asthenia, Asthma, Blood pressure systolic increased, Bronchitis, Burnout syndrome, COVID-19, Chest discomfort, Cough, Diarrhoea, Drug hypersensitivity, Drug ineffective, Dust allergy, Dysphonia, Dyspnoea, Eczema, Fatigue, Forced expiratory volume decreased, Hypoaesthesia, Hypoventilation, Incorrect dose administered, Influenza, Localised infection, Lower respiratory tract infection, Malaise, Middle insomnia, Motor dysfunction, Nasal congestion, Nasopharyngitis, Nausea, Obstructive airways disorder, Oral infection, Oropharyngeal pain, Pain, Pharyngeal swelling, Pyrexia, Rhinorrhoea, Sneezing, Tympanic membrane perforation, Vertebral foraminal stenosis, Vomiting, Weight decreased, Weight increased, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACLIDINIUM BROMIDE, BUDESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
425 | 25061596 |
US |
||
Drug hypersensitivity, Chills, Eye pain, Paranasal sinus discomfort, Sinus pain, Fatigue, Myalgia, Pyrexia, Condition aggravated, Headache, Arthralgia, Pain, Dizziness, |
||||
426 | 25061727 |
CA |
39 | 2 |
Drug hypersensitivity, Illness, Skin plaque, Rebound effect, Stress, Urticaria, Product dose omission issue, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
427 | 25062887 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, CANDESARTAN CILEXETIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
428 | 25063113 |
US |
63 | 1 |
Drug ineffective, Drug hypersensitivity, |
||||
ETANERCEPT, |
||||
429 | 25063188 |
US |
1 | |
Nervous system disorder, Respiratory disorder, Drug hypersensitivity, |
||||
ETANERCEPT, |
||||
430 | 25063199 |
CA |
43 | 2 |
Chronic rhinosinusitis with nasal polyps, Coeliac disease, Dermatitis contact, Drug hypersensitivity, Drug ineffective, Fatigue, Inappropriate schedule of product administration, Incorrect dose administered, Musculoskeletal stiffness, Nasopharyngitis, Skin irritation, Urticaria chronic, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PENICILLIN G BENZATHINE, |
||||
431 | 25063381 |
US |
52 | 2 |
Drug hypersensitivity, |
||||
TETROFOSMIN, TETROFOSMIN, TECHNETIUM TC-99M, |
||||
432 | 25063473 |
CA |
43 | 2 |
Abdominal pain upper, Amnesia, Anxiety, Asthenia, Blepharospasm, Bone erosion, Breast cancer stage III, Bursitis, Crohn^s disease, Delirium, Depression, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Dry mouth, Dyspnoea, Epilepsy, Grip strength decreased, Hepatic cirrhosis, Insomnia, Joint range of motion decreased, Laryngitis, Lower respiratory tract infection, Lung disorder, Lupus vulgaris, Migraine, Muscle spasms, Muscular weakness, Night sweats, Obesity, Paraesthesia, Peripheral venous disease, Red blood cell sedimentation rate increased, Respiratory disorder, Rheumatic fever, Taste disorder, Weight fluctuation, Wheezing, Wound infection, X-ray abnormal, Exostosis, |
||||
RITUXIMAB, CALCIUM, CALCIUM CARBONATE, ANTACID, CANDESARTAN CILEXETIL, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, RAMIPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
433 | 25063863 |
US |
28 | 2 |
Drug hypersensitivity, Swelling face, Urticaria, Rash, |
||||
LEVOTHYROXINE SODIUM, |
||||
434 | 25063930 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
HYDROMORPHONE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, CALCIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, THEOPHYLLINE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, CEFADROXIL, CEFADROXIL, |
||||
435 | 25064041 |
CA |
56 | 2 |
Balance disorder, Depression, Drug hypersensitivity, Ear swelling, Feeling abnormal, Ill-defined disorder, Injection site pain, Insomnia, Malaise, Panic disorder, Papule, Quality of life decreased, Rash macular, Scab, Scratch, Skin haemorrhage, Skin hypertrophy, Skin plaque, Somnolence, Swelling, Swelling face, Urticaria, Weight decreased, Wrong technique in product usage process, Diarrhoea, Dizziness, Fatigue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MORPHINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
436 | 25064239 |
CA |
70 | 1 |
Arthritis, Back pain, Bone cancer, Burning sensation, Chronic spontaneous urticaria, Condition aggravated, Drug hypersensitivity, Generalised oedema, Genital swelling, Gout, Influenza, Lip swelling, Malaise, Mobility decreased, Peripheral swelling, Post procedural infection, Scrotal swelling, Swelling, Throat tightness, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
437 | 25064418 |
CA |
30 | 1 |
Accident at work, Asthma, Blood pressure increased, Bronchitis, COVID-19, Cough, Drug hypersensitivity, Illness, Inappropriate schedule of product administration, Influenza, Malaise, Musculoskeletal pain, Nasal discharge discolouration, Pharyngitis, Product storage error, Productive cough, Sinusitis, Sputum discoloured, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ACLIDINIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, LORAZEPAM, FLUTICASONE FUROATE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
438 | 25064586 |
US |
||
Pulmonary congestion, Chest discomfort, Feeling hot, Dyspnoea, Feeling abnormal, Drug hypersensitivity, Headache, Visual impairment, Hypoaesthesia, Blood pressure increased, Palpitations, Illness, Head discomfort, Feeling hot, |
||||
RAVULIZUMAB, |
||||
439 | 25064620 |
CA |
38 | 2 |
Arthralgia, Blood pressure increased, Breast pain, Bronchitis, Cough, Drug hypersensitivity, Dyspnoea, Eczema, Erythema, Fall, Fluid retention, Hypersensitivity, Menstrual disorder, Nasopharyngitis, Oropharyngeal pain, Rash, Rotator cuff syndrome, Shoulder fracture, Skin discolouration, Sputum discoloured, Thermal burn, Type 2 diabetes mellitus, Urinary tract infection, Urticaria, Weight decreased, Weight increased, Product availability issue, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, CEFPROZIL, LORATADINE, LORATADINE TABLET, MONTELUKAST, ALBUTEROL SULFATE, |
||||
440 | 25064650 |
CN |
19 | 1 |
Malaise, Fatigue, Tachycardia, Palpitations, Angina pectoris, Pain in extremity, Drug hypersensitivity, |
||||
ALIROCUMAB, |
||||
441 | 25064993 |
US |
||
Flatulence, Abdominal distension, Drug hypersensitivity, |
||||
TELOTRISTAT ETHYL, |
||||
442 | 25065146 |
CA |
43 | 2 |
Neck pain, Drug hypersensitivity, Drug intolerance, Gait inability, Intentional product use issue, Muscle injury, Muscle spasms, Musculoskeletal pain, Normal newborn, Contraindicated product administered, Systemic lupus erythematosus, Infusion site reaction, Onychomadesis, Stomatitis, Taste disorder, Psoriatic arthropathy, Type 2 diabetes mellitus, Peripheral venous disease, Rheumatoid arthritis, Peripheral swelling, Paraesthesia, Synovitis, Osteoarthritis, Urticaria, Wheezing, Wound infection, Treatment failure, Therapeutic product effect incomplete, Therapeutic product effect decreased, Product use issue, Product use in unapproved indication, Product quality issue, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, CANDESARTAN, CANDESARTAN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PANTOPRAZOLE, |
||||
443 | 25065349 |
CN |
48 | 1 |
Drug hypersensitivity, |
||||
ERTUGLIFLOZIN, |
||||
444 | 25065356 |
PT |
||
Mucocutaneous disorder, Hypersensitivity, Drug hypersensitivity, |
||||
445 | 25065376 |
US |
75 | 2 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
446 | 25065447 |
PT |
||
Drug hypersensitivity, Type I hypersensitivity, Hypersensitivity, Mucocutaneous disorder, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, |
||||
447 | 25067599 |
|||
Drug hypersensitivity, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, |
||||
448 | 25056317 |
US |
51 | 2 |
Cardiac disorder, Drug hypersensitivity, Rheumatoid arthritis, Memory impairment, Blood glucose increased, Fungal infection, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, DULAGLUTIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
449 | 25056413 |
US |
60 | |
Pneumonia, Asthma, Fall, Drug hypersensitivity, Wrist fracture, Contusion, |
||||
INFLIXIMAB, |
||||
450 | 25056577 |
US |
||
Drug hypersensitivity, |
||||
DULAGLUTIDE, |
||||
451 | 25056844 |
CA |
42 | 2 |
Ear infection, Sinusitis, Crohn^s disease, Weight decreased, Influenza like illness, Drug hypersensitivity, Obstruction, Fatigue, Diarrhoea, Abdominal pain, Nausea, Drug ineffective, COVID-19, Depressed mood, Sleep disorder, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, PREDNISONE, AZATHIOPRINE, |
||||
452 | 25057010 |
US |
52 | 2 |
Drug hypersensitivity, Pruritus, Swelling, Arthralgia, |
||||
TOCILIZUMAB, |
||||
453 | 25057105 |
US |
45 | 1 |
Drug hypersensitivity, Rash, Pruritus, Erythema, Fatigue, Chest pain, |
||||
TENOFOVIR DISOPROXIL FUMARATE, TENOFOVIR DISOPROXIL FUMARATE TABLETS, TENOFOVIR DISOPROXIL FUMARATE, TENOFOVIR DISOPROXIL FUMARATE TABLETS, |
||||
454 | 25057135 |
US |
||
Drug hypersensitivity, |
||||
ONABOTULINUMTOXINA, |
||||
455 | 25057397 |
PK |
2 | |
Drug hypersensitivity, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
456 | 25057562 |
GR |
25 | 1 |
Colitis ulcerative, Tenosynovitis, Drug hypersensitivity, Transaminases increased, |
||||
VEDOLIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
457 | 25057843 |
US |
61 | |
Abdominal discomfort, Flatulence, Drug hypersensitivity, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
458 | 25058368 |
US |
2 | |
Drug hypersensitivity, |
||||
MORPHINE SULFATE, PHENELZINE SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
459 | 25058593 |
US |
2 | |
Drug hypersensitivity, |
||||
ABATACEPT, |
||||
460 | 25058800 |
CA |
72 | 2 |
Abdominal distension, Abdominal pain, Abdominal pain lower, Acne, Arthralgia, Back pain, Blood pressure systolic increased, Blood potassium decreased, Body temperature decreased, Bursitis, Constipation, Contusion, Diarrhoea, Dizziness, Drug hypersensitivity, Dyspnoea, Erythema, Fatigue, Gingival abscess, Headache, Heart rate decreased, Hot flush, Hypokinesia, Hypotension, Incorrect dose administered, Musculoskeletal pain, Nausea, Pneumonia, Product administration error, Productive cough, Renal impairment, Pruritus, Rhinorrhoea, Sciatic nerve injury, Sinusitis, Somnolence, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, ESTRADIOL/NORETHINDRONE ACETATE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, CANDESARTAN, CANDESARTAN, ATENOLOL, ATENOLOL, ATENOLOL, AMLODIPINE, AMOXICILLIN, NAPROXEN, NAPROXEN SODIUM, FLUTICASONE FUROATE, BUDESONIDE, ESTRADIOL, CYCLOBENZAPRINE, DULOXETINE HYDROCHLORIDE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, VENLAFAXINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LANSOPRAZOLE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, NAPROXEN, NAPROXEN SODIUM, ROSUVASTATIN, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN E, CREAM, |
||||
461 | 25058954 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Oedema, Pneumonia, Respiratory tract infection, Wheezing, Pain, Vomiting, |
||||
RITUXIMAB, OMALIZUMAB, |
||||
462 | 25058993 |
CA |
2 | |
Asthma, Chest pain, Drug hypersensitivity, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Vomiting, |
||||
RITUXIMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE BESYLATE, CALCIUM, CLONAZEPAM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, MONTELUKAST SODIUM, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, NEOMYCIN OINTMENT, CEFADROXIL, POLYMYXIN B SULFATE, |
||||
463 | 25059015 |
CA |
43 | 2 |
Pancreatitis, Liver disorder, Systemic lupus erythematosus, Breast cancer stage III, Colitis ulcerative, Delirium, Dislocation of vertebra, Duodenal ulcer perforation, Pericarditis, Abdominal discomfort, Porphyria acute, Psoriatic arthropathy, Rectal haemorrhage, Rheumatoid arthritis, Wound infection, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Discomfort, Underdose, Drug hypersensitivity, Dry mouth, Fatigue, Feeling hot, Fibromyalgia, Frequent bowel movements, Gait disturbance, Grip strength decreased, Inflammation, Irritable bowel syndrome, Joint range of motion decreased, Laboratory test abnormal, Lip dry, Memory impairment, Mobility decreased, Muscle spasms, Muscular weakness, Musculoskeletal pain, Night sweats, Obesity, Oedema peripheral, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Adverse event, Amnesia, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Osteoarthritis, Pain in extremity, Paraesthesia, Peripheral venous disease, Rash, Rheumatoid factor positive, Road traffic accident, Sciatica, Swelling, Synovitis, Vomiting, Weight decreased, Weight increased, Wheezing, White blood cell count increased, Wound, Therapy non-responder, Dizziness, Off label use, Intentional product misuse, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, |
||||
464 | 25059178 |
73 | 2 | |
Drug hypersensitivity, |
||||
METHENAMINE HIPPURATE, ERGOCALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
465 | 25059230 |
IT |
58 | 2 |
Drug hypersensitivity, |
||||
CARBOPLATIN, |
||||
466 | 25059425 |
US |
77 | 2 |
Gastric perforation, Drug hypersensitivity, Pain, Constipation, |
||||
UPADACITINIB, |
||||
467 | 25059608 |
US |
2 | |
Drug hypersensitivity, Swelling face, Periorbital haemorrhage, Oral discomfort, Feeling abnormal, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
468 | 25059644 |
CA |
36 | 2 |
Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Fatigue, Fluid retention, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infection, Infusion related reaction, Joint swelling, Pain, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Upper respiratory tract infection, |
||||
ABATACEPT, ABACAVIR SULFATE, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALPRAZOLAM, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROBROMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOLUTEGRAVIR SODIUM, ETANERCEPT, FLUTICASONE PROPIONATE, FLUCONAZOLE, FLUTICASONE PROPIONATE, FUROSEMIDE, GABAPENTIN, ADALIMUMAB, INFLIXIMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, LAMIVUDINE, LAMIVUDINE ORAL, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, PROGESTERONE, PSYLLIUM HUSK, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, MELATONIN, TEMAZEPAM, BUPROPION HYDROCHLORIDE, |
||||
469 | 25059754 |
CN |
||
Off label use, Drug hypersensitivity, |
||||
IBUPROFEN, |
||||
470 | 25059964 |
US |
2 | |
Insomnia, Blood pressure increased, Panic attack, Drug hypersensitivity, Ill-defined disorder, Neuralgia, Eye disorder, Agitation, Anxiety, Product use in unapproved indication, |
||||
DROPERIDOL, DROPERIDOL, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PROMETHAZINE, ALBUTEROL SULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, POLYETHYLENE GLYCOL 3350, |
||||
471 | 25060145 |
US |
2 | |
Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
472 | 25060502 |
US |
2 | |
Drug hypersensitivity, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
473 | 25060604 |
IL |
2 | |
Drug hypersensitivity, Off label use, Wrong technique in product usage process, |
||||
TIRZEPATIDE, |
||||
474 | 25060734 |
GB |
65 | 2 |
Organ failure, Anxiety, Dry eye, Influenza like illness, Bone loss, Facial wasting, Vision blurred, Renal pain, Alopecia, Drug hypersensitivity, Nose deformity, Adverse drug reaction, Injection site discomfort, Adverse drug reaction, Skin disorder, Dark circles under eyes, Discomfort, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
475 | 25060794 |
US |
2 | |
Drug hypersensitivity, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
476 | 25060855 |
US |
89 | 2 |
Bone pain, Abdominal pain upper, Muscle disorder, Drug hypersensitivity, |
||||
APIXABAN, |
||||
477 | 25064136 |
40 | 1 | |
Drug hypersensitivity, |
||||
478 | 25055874 |
US |
2 | |
Drug hypersensitivity, Rash, |
||||
DUPILUMAB, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
479 | 25054642 |
US |
16 | 1 |
Drug hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
480 | 25054674 |
US |
35 | 2 |
Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
481 | 25054867 |
US |
||
Diarrhoea, Drug hypersensitivity, Product substitution issue, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, FLUOXETINE HYDROCHLORIDE, |
||||
482 | 25055064 |
CA |
41 | 2 |
Angioedema, Arthralgia, Benign ovarian tumour, Blood pressure increased, Bone pain, Drug hypersensitivity, Headache, Joint swelling, Pain, Periorbital swelling, Rash, Respiratory tract congestion, Urticaria, Inappropriate schedule of product administration, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, PREDNISONE, |
||||
483 | 25055136 |
US |
73 | 1 |
Adverse drug reaction, Tremor, Dysstasia, Back pain, Asthenia, Gait disturbance, Drug hypersensitivity, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, ALLOPURINOL, SELEGILINE, AMLODIPINE, PREDNISONE, CARBIDOPA AND LEVODOPA, MIRABEGRON, CARBIDOPA AND LEVODOPA, |
||||
484 | 25055281 |
CA |
||
Acne, Bone disorder, C-reactive protein increased, Eczema, Epistaxis, Joint swelling, Rash pustular, Road traffic accident, Weight increased, Wrist fracture, Arthralgia, Arthritis infective, Bronchitis, Chills, Cough, Drug hypersensitivity, Erythema, Headache, Nasopharyngitis, Pneumonia, Vision blurred, Visual impairment, Therapy partial responder, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, DESOXIMETASONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, PREDNISONE, RANITIDINE, SULFASALAZINE, LEVOTHYROXINE SODIUM, |
||||
485 | 25055510 |
US |
2 | |
Atrial fibrillation, Arrhythmia, Drug hypersensitivity, White blood cell count increased, Abdominal pain upper, Diarrhoea, Abdominal discomfort, Nausea, Visual impairment, Nerve compression, Taste disorder, Ventricular extrasystoles, Chest pain, |
||||
PEGFILGRASTIM, PREDNISONE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
486 | 25055515 |
US |
||
Drug hypersensitivity, |
||||
CANAGLIFLOZIN, |
||||
487 | 25048294 |
CA |
63 | 2 |
Ageusia, Angioedema, Anosmia, Asthma, Dermatitis, Drug hypersensitivity, Dyspnoea, Inappropriate schedule of product administration, Nasal polyps, Pruritus, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MONTELUKAST SODIUM, |
||||
488 | 25048786 |
CA |
54 | 1 |
Chest pain, Abdominal hernia, Blood urine present, Asthma, Blood pressure increased, Chronic pigmented purpura, Decreased activity, Diverticulitis, Drug hypersensitivity, Dyspnoea, Fatigue, Gastroenteritis, Headache, Hiatus hernia, Illness, Inappropriate schedule of product administration, Incorrect dose administered, Infection, Influenza, Inguinal hernia, Middle insomnia, Paraesthesia, Pharyngitis, Pneumonia, Productive cough, Pyrexia, Sinonasal obstruction, Sinus polyp, Sputum discoloured, Subcutaneous abscess, Tachycardia, Thyroid mass, Wheezing, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CARBAMAZEPINE, CARBAMAZEPINE, VALSARTAN, ARIPIPRAZOLE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, IRON, MOMETASONE FUROATE, MOMETASONE, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, NAPROXEN, OXAZEPAM, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, SILDENAFIL CITRATE, SILDENAFIL, SULFASALAZINE, TERBUTALINE SULFATE, TOPIRAMATE, TOPIRAMATE SPINKLE, ALBUTEROL SULFATE, AZITHROMYCIN DIHYDRATE, |
||||
489 | 25049769 |
CO |
61 | 2 |
Necrosis, Disease progression, Drug hypersensitivity, Raynaud^s phenomenon, Disease recurrence, Vaginal haemorrhage, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, CISPLATIN, CARBOPLATIN, PACLITAXEL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
490 | 25049826 |
DE |
7 | 2 |
Condition aggravated, Drug ineffective, Drug hypersensitivity, |
||||
AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, VORICONAZOLE, |
||||
491 | 25050298 |
CA |
58 | 2 |
Bursitis, Asthma, Psoriasis, Food allergy, Retching, Fluid retention, Hepatic enzyme increased, Exposure during pregnancy, Pyrexia, Headache, Foetal death, Overdose, Cardiac failure, Infection, Temperature regulation disorder, Constipation, Drug ineffective, Joint swelling, Back pain, Prescribed overdose, Upper respiratory tract infection, Erythema, Hyponatraemia, Drug intolerance, Rash, Immunodeficiency, Hypertension, Pain, Decreased immune responsiveness, Drug hypersensitivity, Off label use, Product use issue, Hyperhidrosis, Infusion related reaction, Coeliac disease, Fatigue, Thrombocytopenia, Rheumatoid arthritis, Rash erythematous, Nausea, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, MEPERIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, ETANERCEPT, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALBUTEROL SULFATE, ALBUTEROL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, TOCILIZUMAB, FLUTICASONE PROPIONATE, PROGESTERONE, BUPROPION HYDROCHLORIDE, CLONIDINE, |
||||
492 | 25050435 |
US |
27 | 2 |
Drug hypersensitivity, Drug ineffective, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, |
||||
493 | 25050519 |
US |
5 | 2 |
Dyspnoea, Cardiomegaly, Vaginal haemorrhage, Diarrhoea, Headache, Joint swelling, Emotional disorder, Drug hypersensitivity, Illness, Dizziness, Anxiety, Mental disorder, Nausea, Hyperhidrosis, Chest pain, |
||||
MACITENTAN, TREPROSTINIL, AMBRISENTAN, |
||||
494 | 25050540 |
IT |
19 | 1 |
Dyspnoea, Chest pain, Drug hypersensitivity, |
||||
KETOPROFEN, |
||||
495 | 25050868 |
US |
2 | |
Drug hypersensitivity, |
||||
RISANKIZUMAB-RZAA, |
||||
496 | 25051093 |
2 | ||
Mouth ulceration, Rash, Drug hypersensitivity, |
||||
APREMILAST, APREMILAST, ADALIMUMAB, SECUKINUMAB, |
||||
497 | 25051165 |
2 | ||
Drug hypersensitivity, Mouth ulceration, |
||||
SECUKINUMAB, ADALIMUMAB, |
||||
498 | 25051438 |
57 | 2 | |
Drug hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
499 | 25051567 |
US |
60 | 2 |
Headache, Abdominal pain upper, Lymphadenopathy, Photosensitivity reaction, Hyperacusis, Parosmia, Fall, Piloerection, Drug hypersensitivity, Vision blurred, Nausea, Decreased appetite, Insomnia, |
||||
BIMEKIZUMAB, ADALIMUMAB, OMALIZUMAB, |
||||
500 | 25051670 |
US |
1 | |
Drug hypersensitivity, |
||||
PANCRELIPASE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28